Table: begin end state 1 41 cytoplasmic 42 58 transmembrane 59 66 non-cytoplasmic 67 88 transmembrane 89 99 cytoplasmic 100 120 transmembrane 121 125 non-cytoplasmic 126 153 transmembrane 154 165 cytoplasmic 166 191 transmembrane 192 199 non-cytoplasmic 200 219 transmembrane 220 257 cytoplasmic 258 280 transmembrane 281 291 non-cytoplasmic 292 312 transmembrane 313 323 cytoplasmic 324 342 transmembrane 343 347 non-cytoplasmic 348 369 transmembrane 370 384 cytoplasmic 385 409 transmembrane 410 415 non-cytoplasmic 416 436 transmembrane 437 447 cytoplasmic
Input: >Pf6N2E2_388 MQTSLLSNSETHHEHVDDEKKKSMKNVVAGSLFGTALETYDLYLYGTAAALIFAPLFFPG TDEAVSRLASLASFAISFVARPLGSLVLGHFGDRIGRKKLLYLTLIIMGLSTVGIGLLPT YASVGIWAPIMLCVLRFIQGFAFAGEYSGAVLMLLEHAPRRKRGFYAAINNIGPVFGFIA SAGLLLIVSSLLSVEDFYKWGWRIPFIASLALLVVGVFVRSKVAESPVFEKTAEKRAVAK GPDLSPAMRLFTKYPKQLLLVAGANICHFSTFYLFTVFALSYGQKELGLSNAFVLAVAMV AICTHLVIVPFAGAMADRLGRRTMMLIGFAVTALAAFPFWHLFSTGQFLPMVLGSCLFMA GYGLVYGAVPSFTGEAFGPSARFTGFAMATNVGGIIGGGTAPIVGAYLLSHYGSPYAISV YTVVLAAISALCVYLSAETRTINITDE
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server